Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -4,625 | N/A | N/A |
| Depreciation Amortization | N/A | N/A | 6 | N/A | N/A |
| Accounts receivable | N/A | N/A | -894 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | -571 | N/A | N/A |
| Other Working Capital | N/A | N/A | -1,884 | N/A | N/A |
| Other Operating Activity | 0 | 0 | 1,890 | 0 | 0 |
| Operating Cash Flow | $N/A | $N/A | $-6,078 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 3,497 | N/A | N/A |
| PPE Investments | N/A | N/A | -5 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $3,492 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | N/A | N/A | -92 | N/A | N/A |
| Beginning Cash Position | N/A | N/A | 4,390 | N/A | N/A |
| End Cash Position | N/A | N/A | 1,712 | N/A | N/A |
| Net Cash Flow | $N/A | $N/A | $-2,678 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | -6,078 | N/A | N/A |
| Capital Expenditure | N/A | N/A | -5 | N/A | N/A |
| Free Cash Flow | 0 | 0 | -6,083 | 0 | 0 |